Behrouz Shademan

659 total citations
43 papers, 445 citations indexed

About

Behrouz Shademan is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Behrouz Shademan has authored 43 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Behrouz Shademan's work include MicroRNA in disease regulation (10 papers), CRISPR and Genetic Engineering (6 papers) and CAR-T cell therapy research (5 papers). Behrouz Shademan is often cited by papers focused on MicroRNA in disease regulation (10 papers), CRISPR and Genetic Engineering (6 papers) and CAR-T cell therapy research (5 papers). Behrouz Shademan collaborates with scholars based in Iran, Türkiye and Netherlands. Behrouz Shademan's co-authors include Alireza Nourazarian, Masoud Nikanfar, Alireza Isazadeh, Saba Hajazimian, Javad Behroozi, Çığır Biray Avcı, Behzad Baradaran, Pouya Goleij, Cumhur Gündüz and Fatemeh Khaki‐Khatibi and has published in prestigious journals such as Frontiers in Immunology, Life Sciences and Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.

In The Last Decade

Behrouz Shademan

40 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Behrouz Shademan Iran 13 238 122 89 51 45 43 445
Wan Li China 14 358 1.5× 155 1.3× 104 1.2× 74 1.5× 35 0.8× 16 625
Qianliang Wang China 12 252 1.1× 89 0.7× 53 0.6× 69 1.4× 47 1.0× 30 471
Zhun Wang China 15 215 0.9× 97 0.8× 178 2.0× 72 1.4× 33 0.7× 43 601
Lifeng Yuan United States 9 266 1.1× 149 1.2× 86 1.0× 92 1.8× 24 0.5× 9 497
Jingyun Lee United States 14 421 1.8× 110 0.9× 57 0.6× 36 0.7× 27 0.6× 46 613
Jianyu Yang China 15 311 1.3× 103 0.8× 45 0.5× 43 0.8× 35 0.8× 47 563
Bing Zhu China 14 217 0.9× 120 1.0× 42 0.5× 52 1.0× 34 0.8× 47 553
Isao Kawahara Japan 17 247 1.0× 133 1.1× 109 1.2× 37 0.7× 32 0.7× 46 602

Countries citing papers authored by Behrouz Shademan

Since Specialization
Citations

This map shows the geographic impact of Behrouz Shademan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behrouz Shademan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behrouz Shademan more than expected).

Fields of papers citing papers by Behrouz Shademan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behrouz Shademan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behrouz Shademan. The network helps show where Behrouz Shademan may publish in the future.

Co-authorship network of co-authors of Behrouz Shademan

This figure shows the co-authorship network connecting the top 25 collaborators of Behrouz Shademan. A scholar is included among the top collaborators of Behrouz Shademan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behrouz Shademan. Behrouz Shademan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nourazarian, Alireza, et al.. (2025). The Interplay Between Viral Infection and Cell Death: A Ping‐Pong Effect. Advances in Virology. 2025(1). 5750575–5750575. 1 indexed citations
2.
Shademan, Behrouz, et al.. (2024). Methylglyoxal Affects the Expression of miR-125b, miR-107, and Oxidative Stress Pathway-associated Genes in the SH-SY5Y Cell Line. Advanced Pharmaceutical Bulletin. 14(2). 419–425. 1 indexed citations
3.
Bağca, Bakiye Göker, et al.. (2024). Precision oncology: Using cancer genomics for targeted therapy advancements. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(1). 189250–189250. 1 indexed citations
4.
Shademan, Behrouz, et al.. (2024). Exploring the intricate relationship between miRNA dysregulation and breast cancer development: insights into the impact of environmental chemicals. Frontiers in Immunology. 15. 1333563–1333563. 5 indexed citations
5.
Zolbin, Masoumeh Majidi, et al.. (2024). Optimizing cancer treatment: the synergistic potential of CAR-T cell therapy and CRISPR/Cas9. Frontiers in Immunology. 15. 1462697–1462697. 13 indexed citations
6.
Alizadeh, Rafieh, Alimohamad Asghari, Farzad Taghizadeh‐Hesary, et al.. (2023). Intranasal delivery of stem cells labeled by nanoparticles in neurodegenerative disorders: Challenges and opportunities. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 15(6). e1915–e1915. 4 indexed citations
7.
Shademan, Behrouz, et al.. (2023). Relationship between miRNA-21, miRNA-155, and miRNA-182 expression and inflammatory factors in cerebrospinal fluid from patients with multiple sclerosis. Clinical Neurology and Neurosurgery. 232. 107873–107873. 7 indexed citations
9.
Asl, Elmira Roshani, et al.. (2023). MicroRNA targeting: A novel therapeutic intervention for ovarian cancer. Biochemistry and Biophysics Reports. 35. 101519–101519. 10 indexed citations
10.
Shademan, Behrouz, et al.. (2023). Melatonin: a promising neuroprotective agent for cerebral ischemia-reperfusion injury. Frontiers in Aging Neuroscience. 15. 1227513–1227513. 20 indexed citations
11.
Shademan, Behrouz, et al.. (2022). MicroRNAs as a New Target for Alzheimer's Disease Treatment. MicroRNA. 12(1). 3–12. 9 indexed citations
12.
Shademan, Behrouz, et al.. (2022). MicroRNAs as Targets for Cancer Diagnosis: Interests and Limitations. Advanced Pharmaceutical Bulletin. 13(3). 435–445. 24 indexed citations
13.
Shademan, Behrouz, et al.. (2022). Enhanced Anti-cancer Potency Using a Combination of Oleanolic Acid and Maslinic Acid to Control Treatment Resistance in Breast Cancer. Advanced Pharmaceutical Bulletin. 13(3). 611–620. 5 indexed citations
14.
Shademan, Behrouz, et al.. (2022). Gene polymorphism of leptin and risk for heart disease, obesity, and high BMI: a systematic review and pooled analysis in adult obese subjects. Hormone Molecular Biology and Clinical Investigation. 44(1). 11–20. 1 indexed citations
15.
Shademan, Behrouz, et al.. (2021). CAR T Cells: Cancer Cell Surface Receptors Are the Target for Cancer Therapy. Advanced Pharmaceutical Bulletin. 12(3). 476–489. 9 indexed citations
16.
17.
Nourazarian, Alireza, et al.. (2021). Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease. Neuroscience Letters. 764. 136221–136221. 22 indexed citations
18.
Kutbay, Nilüfer Özdemir, Çığır Biray Avcı, Banu Şarer Yürekli, et al.. (2020). Effects of metformin and pioglitazone combination on apoptosis and AMPK/mTOR signaling pathway in human anaplastic thyroid cancer cells. Journal of Biochemical and Molecular Toxicology. 34(10). e22547–e22547. 27 indexed citations
20.
Shademan, Behrouz, et al.. (2020). Investigation of the miRNA146a and miRNA155 gene expression levels in patients with multiple sclerosis. Journal of Clinical Neuroscience. 78. 189–193. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026